Icon

DEXMEDETOMIDINE HYDROCHLORIDE (nda206628)- (EQ 400MCG BASE/4ML (EQ 100MCG BASE/ML),EQ 1MG BASE/10ML (EQ 100MCG BASE/ML),EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML),EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML))

DEXMEDETOMIDINE HYDROCHLORIDE HQ SPCLT PHARMA
EQ 400MCG BASE/4ML (EQ 100MCG BASE/ML),EQ 1MG BASE/10ML (EQ 100MCG BASE/ML),EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML),EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML)
No Yes
Expired Expired
None None
None No
Dexmedetomidine Hydrochloride Injection is a central alpha-2 adrenergic agonist indicated for: • Sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting. Administer Dexmedetomidine Hydrochloride Injection by continuous infusion not to exceed 24 hours. • Sedation of non-intubated patients prior to and/or during surgical and other procedures.
0 0 0
Total Other Developers 9
Drugs with Suitability No
EQ 400MCG BASE/4ML (EQ 100MCG BASE/ML) ** ** - - -
EQ 1MG BASE/10ML (EQ 100MCG BASE/ML) ** ** - - -
EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML) ** ** - - -
EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.